HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples